REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/03/2026
Back to search
Official data from USPTO
ZYEPTI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/03/2026
Trademark type
Word
Nice classes
5
Filing date
02/25/2020
Registration date
08/03/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/03/2021
Last transaction
08/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
US
Examiner
KOVALSKY, LAURA G
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Lundbeck Seattle BioPharmaceuticals Inc.
H. Lundbeck A/S
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and medical preparations and substances for use in the preventionmanagement and treatment of headachesmigrainespainneurological disorders and conditions; Vaccines; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; Pharmaceutical preparations and substances for the prevention and treatment of dementiaAlzheimer's disease and disorderdizzinessseizuresstrokedepressioncognitive impairmentcognitive disorders and diseasesmood disorderspsychosisanxietyapathyepilepsyLennox-Gastaut syndrome (LGS)sclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderfallsmovement disorders and diseasestremorschizophreniabipolar disorder and diseasemaniaADHDPTSDagitationaggressionautismmelancholyOCDTourette's syndromePSPrestlessnessakathisiafatiguesomnolencenauseacancermigraineheadachespainalcoholism and dependency; Preparationssubstancesreagents and agents for diagnostic and medical purposesfor use in the preventionmanagement and treatment of headachesmigrainespainneurological disorders and conditions
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/20/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/07/2022
FIMP
FINAL DISPOSITION PROCESSED
01/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/03/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/18/2021
PUBO
PUBLISHED FOR OPPOSITION
05/18/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/17/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/28/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2021
ALIE
ASSIGNED TO LIE
03/25/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/24/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/15/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/15/2021
CNSL
SUSPENSION LETTER WRITTEN
03/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2021
ALIE
ASSIGNED TO LIE
02/25/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2020
DCPN
CHANGE OF OWNER RECEIVED FROM IB
11/09/2020
RFNT
REFUSAL PROCESSED BY IB
10/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/23/2020
RFRR
REFUSAL PROCESSED BY MPU
09/23/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/18/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/18/2020
CNRT
NON-FINAL ACTION WRITTEN
08/17/2020
DOCK
ASSIGNED TO EXAMINER
08/14/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/13/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/06/2020
Continuous trademark protection
Get notified about every new filing that threatens ZYEPTI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.